Global Intranasal Drug Delivery Market to Reach $71.3 Billion by 2026

New York, April 19, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Intranasal Drug Delivery Industry" - https://www.reportlinker.com/p05436898/?utm_source=GNW

-Online interactive peer-to-peer collaborative bespoke updates

-Access to our digital archives and MarketGlass Research Platform

-Complimentary updates for one year



Global Intranasal Drug Delivery Market to Reach $71.3 Billion by 2026



As a direct result of technological advancements and increasing awareness among physicians and patients, a number of drug delivery options, including implantable, injectable, ocular, nasal, pulmonary, topical, transdermal, and transmucosal, are available to patients and care providers. The mode of delivering drugs to the target area of the patient body plays a decisive role in the effectiveness of the therapy. Pulmonary and nasal are the most popular approaches for drug delivery, owing to the ease of administration, particularly for patients requiring long-term therapy, improvement in quality of life of patients, the improved efficacy and bioavailability of administered drugs, lower risk of drug overdose, and easier compliance with stringent pharmaceutical regulations.



Nasal drug delivery route is suitable for systematic drug delivery, needleless vaccination, and for drug candidates with low oral absorption or vulnerable to first-pass effect in the human body. Intranasal drug delivery is a method involving the administration of drugs through the nasal cavity to produce a systemic or local therapeutic activity, with the exceptional vascular structure of the human nose making it suitable for administering small molecule drugs and biologics, and highly effective for treating local infections, and acute and chronic allergies. A plethora of local anesthetics, antibiotics, antihistamines, bronchodilators, calcium, corticosteroids, decongestant sprays, pain relief drugs, snuffs, supplements, vasoconstrictors and other drugs are administered through the intranasal route for chronic and acute treatments. Intranasal drugs are primarily administered in the form of ointments, sprays, powders, gels, and drops for treating allergic infections, analgesics, osteoporosis, vaccinations, pain management, anxiety, depression, and sexual dysfunction, among others.



Amid the COVID-19 crisis, the global market for Intranasal Drug Delivery estimated at US$49.5 Billion in the year 2020, is projected to reach a revised size of US$71.3 Billion by 2026, growing at a CAGR of 6.2% over the analysis period. Liquid Delivery Devices, one of the segments analyzed in the report, is projected to grow at a 5.8% CAGR to reach US$31.3 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Powder Delivery Devices segment is readjusted to a revised 7% CAGR for the next 7-year period. This segment currently accounts for a 31.5% share of the global Intranasal Drug Delivery market.



The U.S. Market is Estimated at $21.9 Billion in 2021, While China is Forecast to Reach $5.7 Billion by 2026



The Intranasal Drug Delivery market in the U.S. is estimated at US$21.9 Billion in the year 2021. The country currently accounts for a 42.05% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$5.7 Billion in the year 2026 trailing a CAGR of 8.4% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.8% and 5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.9% CAGR while Rest of European market (as defined in the study) will reach US$6.1 Billion by the close of the analysis period.



North America represents the leading global market for intranasal drug delivery, driven by the growing prevalence of respiratory disorders, such as asthma and COPD; the high adoption of drug delivery technique in healthcare institutions; and the growing affinity of patients for affordable generic drugs. Technological developments are among the major factors driving the growth of the US drug delivery industry. The US drug delivery market has recorded significant developments in the past few years, and the search for new technologies represent a perennial effort aimed at achieving incremental benefits. In addition to scientific advancements, other factors and issues such as availability of financial support, changing scientific policies, therapeutic protocols, government regulations, and market forces have a bearing on the drug delivery market.



Europe represents the second largest market for intranasal drug delivery, trailed by the Asia-Pacific. The European market is expected to showcase fast growth fueled by the rising prevalence of chronic illnesses targeted for intranasal therapeutics, the growing markets for geriatric care, pediatric care, and home healthcare. Emerging countries in Asia, the Middle East and Latin America, are expected to spearhead the growth of the global intranasal drug delivery market by virtue of the large pool of target patients, relatively stronger GDP growth, improving public and private healthcare infrastructure, increasing healthcare spending, and increasing penetration of medical insurance. The Asia-Pacific, led by countries such as India and China, is expected to exhibit strong growth through the burgeoning population, rising per capita incomes, increasing patient awareness about the benefits of intranasal drugs, and increasing investment from drug companies.



Pressurized Metered Dose Inhalers Segment to Reach $12 Billion by 2026



In the global Pressurized Metered Dose Inhalers segment, USA, Canada, Japan, China and Europe will drive the 6.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$7 Billion in the year 2020 will reach a projected size of US$10.6 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$837.6 Million by the year 2026, while Latin America will expand at a 7.5% CAGR through the analysis period.

Select Competitors (Total 77 Featured) -

• AptarGroup, Inc.
• AstraZeneca Plc.
• Becton Dickinson and Company
• GlaxoSmithKline Plc.
• Johnson & Johnson Inc.
• Merck & Co., Inc.
• Nemera
• Novartis AG
• OptiNose US Inc.
• Pfizer, Inc.

Read the full report: https://www.reportlinker.com/p05436898/?utm_source=GNW



I. METHODOLOGY



II. EXECUTIVE SUMMARY



1. MARKET OVERVIEW

Impact of Covid-19 and a Looming Global Recession

2020: A Year of Disruption & Transformation

As the Race between the Virus & Vaccines Intensifies, Where is

the World Economy Headed in 2021?

World Economic Growth Projections (Real GDP, Annual % Change)

for 2020 through 2022

Promising Intranasal Vaccines to Nip COVID-19 Virus at Point of

Entry

Rapid Progress despite Roadblocks

Nasal Sprays for Protection against COVID-19 Infection

Influencer Market Insights

World Market Trajectories

Intranasal Drug Delivery - Global Key Competitors Percentage

Market Share in 2022 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for

Players Worldwide in 2022 (E)

Intranasal Drug Delivery: A Prelude

Leading Indications and APIs Amenable to Nasal Drug Delivery

Regional Market Analysis

Why Nasal Application is Garnering Notable Attention for Drug

Delivery

Limitations of Intranasal Drug Delivery

Overview of the Traditional Drug Administration Routes,

Molecular Weight Capabilities, and Dosage Range

Drug Delivery Pathways Related to the Nasal Cavity

Systemic delivery and Local Delivery Routes

Differences between Systemic Delivery and Local Effects

Challenges Involved In Formulating Nasal Drugs

Intranasal Cavity: An Attractive Drug Delivery Route to Cross

the Blood Brain Barrier

Nose-to-Brain Drug Delivery: An Evolving Area of Interest

Factors Inhibiting Nose-to-Brain Transportation of Drugs

Bioavailability: An Important Facet of Intranasal Drug Delivery

Traditional Vs. Advanced Intranasal Drug Formulation Types

Type of Nasal Delivery Vehicles with Select Therapeutic Agents

and Area of Application

Select FDA-Approved Nasal Products Compound (Trade Name)

Indication Dosage Form Year

Recent Market Activity



2. FOCUS ON SELECT PLAYERS



3. MARKET TRENDS & DRIVERS

Rise in Prevalence of COPD Drives Opportunities

Global Prevalence of COPD: Percentage of Men and Women Affected

by Age Group

Pharmaceutical and Medical Device Companies Vie to Develop New

Intranasal Therapeutics for Allergic Rhinitis Patients

Prevalence Percentage of COPD, Asthma, and Allergic Rhinitis

for Select Countries

The US - FDA Approved Intranasal Corticosteroids (INAC) and

Intranasal Antihistamines (INAH) for Treating Allergic

Rhinitis

The US - FDA Approved Nasal Spray Medication Types (excluding

INAC & INAH) for Allergic Rhinitis Treatment

Intranasal Corticosteroids : A Potential Treatment for

Debilitating Chronic Rhinosinusitis Disease

Select Intranasal Corticosteroid Brands for Adult and Pediatric

Usage

Manufacturers Focus on Improved Nasal Delivery Platforms

Controlled Release Technology is the Buzz Word

Research on Nanocarrier-Based Intranasal Drug Delivery Systems

Picks Up Pace

Potential Role in Treatment and Management of Coronavirus

Infection

Self-Administration of Drugs Brings Intranasal Drug Delivery

into the Spotlight

Nasal Drug Delivery Offers New Opportunities for Drug

Developers as Patent Cliffs Usher in Dusk of Blockbuster Era

Top Nasal Inhalers, Sprays, and Drops Brands in the US (2019):

Percentage Share Breakdown of Dollar Sales

Active Pharmaceutical Ingredients Used in Formulations for

Nasal Drug Delivery with Related Indications

Increasing R&D Unlocks New Therapeutic Areas for Nasal Drug

Delivery

Intranasal Therapeutics Delivery: A High Potential Method for

Treating CNS Diseases

Researchers Develop Nasal Spray Treatment for Parkinson?s Disease

Future Opportunities in CNS Space

Intranasal Delivery of Stem Cells: A Primary Strategy for

Treatment of CNS Disorders

Intranasal Delivery of Stem Cells: Limitations

Diagnosed Prevalence Cases of Parkinson?s Disease Across Select

Countries

Intranasal Delivery of Peptide-Based Pharmaceuticals

Select Protein, Peptide & Non-Peptide Drugs Available as Nasal

Spray Solutions in the Marketplace

Select List of Nasal Biologics Available in the Market

Benefits of Bi-Directional Nasal Drug Delivery

Rise in Interest in Preservative-free Nasal Spray Formulations

Burgeoning Geriatric Populace Spurs Growing Demand for

Intranasal Drug Therapies

Global Aging Population Statistics for the 65+ Age Group in

Million by Geographic Region for the Years 2019, 2025, 2035

and 2050

Appendix: List of Select Intranasal Drugs in Phase III Clinical

Trials

List of Select Intranasal Drugs for Pain Management in Phase

III Clinical Trials

Select Intranasal Drugs for Cancer in Phase III Clinical Trials

Select Intranasal Drugs for Diabetes in Phase III Clinical Trials

Select Intranasal Drugs for Nasal Polyps in Phase III Clinical

Trials

Select Intranasal Drugs for Depression in Phase III Clinical

Trials

Select Intranasal Drugs for Chronic Sinusitis in Phase III

Clinical Trials

Select Intranasal Drugs for Migraine in Phase III Clinical Trials

Intranasal Drugs for Allergic Rhinitis in Phase III Clinical

Trials

Select Intranasal Drugs for Diabetes Mellitus in Phase III

Clinical Trials

Select Intranasal Drugs for Covid-19 in Phase III Clinical Trials

Select Intranasal Drugs for Covid-19 in Phase III Clinical Trials



4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for

Liquid Delivery Devices by Geographic Region - USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa Markets - Independent Analysis of Annual Sales in

US$ Million for Years 2020 through 2027 and % CAGR



Table 2: World Historic Review for Liquid Delivery Devices by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2016 through 2019 and % CAGR



Table 3: World 11-Year Perspective for Liquid Delivery Devices

by Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2016, 2021 & 2027



Table 4: World Recent Past, Current & Future Analysis for

Powder Delivery Devices by Geographic Region - USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa Markets - Independent Analysis of Annual Sales in

US$ Million for Years 2020 through 2027 and % CAGR



Table 5: World Historic Review for Powder Delivery Devices by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2016 through 2019 and % CAGR



Table 6: World 11-Year Perspective for Powder Delivery Devices

by Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2016, 2021 & 2027



Table 7: World Recent Past, Current & Future Analysis for

Pressurized Metered Dose Inhalers by Geographic Region - USA,

Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa Markets - Independent Analysis of Annual

Sales in US$ Million for Years 2020 through 2027 and % CAGR



Table 8: World Historic Review for Pressurized Metered Dose

Inhalers by Geographic Region - USA, Canada, Japan, China,

Europe, Asia-Pacific, Latin America, Middle East and Africa

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2016 through 2019 and % CAGR



Table 9: World 11-Year Perspective for Pressurized Metered Dose

Inhalers by Geographic Region - Percentage Breakdown of Value

Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,

Latin America, Middle East and Africa for Years 2016, 2021 &

2027



Table 10: World Recent Past, Current & Future Analysis for

Other Product Types by Geographic Region - USA, Canada, Japan,

China, Europe, Asia-Pacific, Latin America, Middle East and

Africa Markets - Independent Analysis of Annual Sales in US$

Million for Years 2020 through 2027 and % CAGR



Table 11: World Historic Review for Other Product Types by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2016 through 2019 and % CAGR



Table 12: World 11-Year Perspective for Other Product Types by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2016, 2021 & 2027



Table 13: World Recent Past, Current & Future Analysis for

Respiratory Disorders by Geographic Region - USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa Markets - Independent Analysis of Annual Sales in

US$ Million for Years 2020 through 2027 and % CAGR



Table 14: World Historic Review for Respiratory Disorders by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2016 through 2019 and % CAGR



Table 15: World 11-Year Perspective for Respiratory Disorders

by Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2016, 2021 & 2027



Table 16: World Recent Past, Current & Future Analysis for

Neurological Disorders by Geographic Region - USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa Markets - Independent Analysis of Annual Sales in

US$ Million for Years 2020 through 2027 and % CAGR



Table 17: World Historic Review for Neurological Disorders by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2016 through 2019 and % CAGR



Table 18: World 11-Year Perspective for Neurological Disorders

by Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2016, 2021 & 2027



Table 19: World Recent Past, Current & Future Analysis for Pain

Management by Geographic Region - USA, Canada, Japan, China,

Europe, Asia-Pacific, Latin America, Middle East and Africa

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2020 through 2027 and % CAGR



Table 20: World Historic Review for Pain Management by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2016 through 2019 and % CAGR



Table 21: World 11-Year Perspective for Pain Management by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2016, 2021 & 2027



Table 22: World Recent Past, Current & Future Analysis for

Other Applications by Geographic Region - USA, Canada, Japan,

China, Europe, Asia-Pacific, Latin America, Middle East and

Africa Markets - Independent Analysis of Annual Sales in US$

Million for Years 2020 through 2027 and % CAGR



Table 23: World Historic Review for Other Applications by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2016 through 2019 and % CAGR



Table 24: World 11-Year Perspective for Other Applications by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2016, 2021 & 2027



Table 25: World Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Geographic Region - USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa Markets - Independent Analysis of Annual Sales in

US$ Million for Years 2020 through 2027 and % CAGR



Table 26: World Historic Review for Intranasal Drug Delivery by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2016 through 2019 and % CAGR



Table 27: World 11-Year Perspective for Intranasal Drug

Delivery by Geographic Region - Percentage Breakdown of Value

Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,

Latin America, Middle East and Africa Markets for Years 2016,

2021 & 2027



III. MARKET ANALYSIS



UNITED STATES

Intranasal Drug Delivery Market Presence - Strong/Active/Niche/

Trivial - Key Competitors in the United States for 2022 (E)

Table 28: USA Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Product Type - Liquid Delivery

Devices, Powder Delivery Devices, Pressurized Metered Dose

Inhalers and Other Product Types - Independent Analysis of

Annual Sales in US$ Million for the Years 2020 through 2027 and

% CAGR



Table 29: USA Historic Review for Intranasal Drug Delivery by

Product Type - Liquid Delivery Devices, Powder Delivery

Devices, Pressurized Metered Dose Inhalers and Other Product

Types Markets - Independent Analysis of Annual Sales in US$

Million for Years 2016 through 2019 and % CAGR



Table 30: USA 11-Year Perspective for Intranasal Drug Delivery

by Product Type - Percentage Breakdown of Value Sales for

Liquid Delivery Devices, Powder Delivery Devices, Pressurized

Metered Dose Inhalers and Other Product Types for the Years

2016, 2021 & 2027



Table 31: USA Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Application - Respiratory

Disorders, Neurological Disorders, Pain Management and Other

Applications - Independent Analysis of Annual Sales in US$

Million for the Years 2020 through 2027 and % CAGR



Table 32: USA Historic Review for Intranasal Drug Delivery by

Application - Respiratory Disorders, Neurological Disorders,

Pain Management and Other Applications Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2016 through

2019 and % CAGR



Table 33: USA 11-Year Perspective for Intranasal Drug Delivery

by Application - Percentage Breakdown of Value Sales for

Respiratory Disorders, Neurological Disorders, Pain Management

and Other Applications for the Years 2016, 2021 & 2027



CANADA

Table 34: Canada Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Product Type - Liquid Delivery

Devices, Powder Delivery Devices, Pressurized Metered Dose

Inhalers and Other Product Types - Independent Analysis of

Annual Sales in US$ Million for the Years 2020 through 2027 and

% CAGR



Table 35: Canada Historic Review for Intranasal Drug Delivery

by Product Type - Liquid Delivery Devices, Powder Delivery

Devices, Pressurized Metered Dose Inhalers and Other Product

Types Markets - Independent Analysis of Annual Sales in US$

Million for Years 2016 through 2019 and % CAGR



Table 36: Canada 11-Year Perspective for Intranasal Drug

Delivery by Product Type - Percentage Breakdown of Value Sales

for Liquid Delivery Devices, Powder Delivery Devices,

Pressurized Metered Dose Inhalers and Other Product Types for

the Years 2016, 2021 & 2027



Table 37: Canada Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Application - Respiratory

Disorders, Neurological Disorders, Pain Management and Other

Applications - Independent Analysis of Annual Sales in US$

Million for the Years 2020 through 2027 and % CAGR



Table 38: Canada Historic Review for Intranasal Drug Delivery

by Application - Respiratory Disorders, Neurological Disorders,

Pain Management and Other Applications Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2016 through

2019 and % CAGR



Table 39: Canada 11-Year Perspective for Intranasal Drug

Delivery by Application - Percentage Breakdown of Value Sales

for Respiratory Disorders, Neurological Disorders, Pain

Management and Other Applications for the Years 2016, 2021 &

2027



JAPAN

Intranasal Drug Delivery Market Presence - Strong/Active/Niche/

Trivial - Key Competitors in Japan for 2022 (E)

Table 40: Japan Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Product Type - Liquid Delivery

Devices, Powder Delivery Devices, Pressurized Metered Dose

Inhalers and Other Product Types - Independent Analysis of

Annual Sales in US$ Million for the Years 2020 through 2027 and

% CAGR



Table 41: Japan Historic Review for Intranasal Drug Delivery by

Product Type - Liquid Delivery Devices, Powder Delivery

Devices, Pressurized Metered Dose Inhalers and Other Product

Types Markets - Independent Analysis of Annual Sales in US$

Million for Years 2016 through 2019 and % CAGR



Table 42: Japan 11-Year Perspective for Intranasal Drug

Delivery by Product Type - Percentage Breakdown of Value Sales

for Liquid Delivery Devices, Powder Delivery Devices,

Pressurized Metered Dose Inhalers and Other Product Types for

the Years 2016, 2021 & 2027



Table 43: Japan Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Application - Respiratory

Disorders, Neurological Disorders, Pain Management and Other

Applications - Independent Analysis of Annual Sales in US$

Million for the Years 2020 through 2027 and % CAGR



Table 44: Japan Historic Review for Intranasal Drug Delivery by

Application - Respiratory Disorders, Neurological Disorders,

Pain Management and Other Applications Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2016 through

2019 and % CAGR



Table 45: Japan 11-Year Perspective for Intranasal Drug

Delivery by Application - Percentage Breakdown of Value Sales

for Respiratory Disorders, Neurological Disorders, Pain

Management and Other Applications for the Years 2016, 2021 &

2027



CHINA

Intranasal Drug Delivery Market Presence - Strong/Active/Niche/

Trivial - Key Competitors in China for 2022 (E)

Table 46: China Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Product Type - Liquid Delivery

Devices, Powder Delivery Devices, Pressurized Metered Dose

Inhalers and Other Product Types - Independent Analysis of

Annual Sales in US$ Million for the Years 2020 through 2027 and

% CAGR



Table 47: China Historic Review for Intranasal Drug Delivery by

Product Type - Liquid Delivery Devices, Powder Delivery

Devices, Pressurized Metered Dose Inhalers and Other Product

Types Markets - Independent Analysis of Annual Sales in US$

Million for Years 2016 through 2019 and % CAGR



Table 48: China 11-Year Perspective for Intranasal Drug

Delivery by Product Type - Percentage Breakdown of Value Sales

for Liquid Delivery Devices, Powder Delivery Devices,

Pressurized Metered Dose Inhalers and Other Product Types for

the Years 2016, 2021 & 2027



Table 49: China Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Application - Respiratory

Disorders, Neurological Disorders, Pain Management and Other

Applications - Independent Analysis of Annual Sales in US$

Million for the Years 2020 through 2027 and % CAGR



Table 50: China Historic Review for Intranasal Drug Delivery by

Application - Respiratory Disorders, Neurological Disorders,

Pain Management and Other Applications Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2016 through

2019 and % CAGR



Table 51: China 11-Year Perspective for Intranasal Drug

Delivery by Application - Percentage Breakdown of Value Sales

for Respiratory Disorders, Neurological Disorders, Pain

Management and Other Applications for the Years 2016, 2021 &

2027



EUROPE

Intranasal Drug Delivery Market Presence - Strong/Active/Niche/

Trivial - Key Competitors in Europe for 2022 (E)

Table 52: Europe Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Product Type - Liquid Delivery

Devices, Powder Delivery Devices, Pressurized Metered Dose

Inhalers and Other Product Types - Independent Analysis of

Annual Sales in US$ Million for the Years 2020 through 2027 and

% CAGR



Table 53: Europe Historic Review for Intranasal Drug Delivery

by Product Type - Liquid Delivery Devices, Powder Delivery

Devices, Pressurized Metered Dose Inhalers and Other Product

Types Markets - Independent Analysis of Annual Sales in US$

Million for Years 2016 through 2019 and % CAGR



Table 54: Europe 11-Year Perspective for Intranasal Drug

Delivery by Product Type - Percentage Breakdown of Value Sales

for Liquid Delivery Devices, Powder Delivery Devices,

Pressurized Metered Dose Inhalers and Other Product Types for

the Years 2016, 2021 & 2027



Table 55: Europe Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Application - Respiratory

Disorders, Neurological Disorders, Pain Management and Other

Applications - Independent Analysis of Annual Sales in US$

Million for the Years 2020 through 2027 and % CAGR



Table 56: Europe Historic Review for Intranasal Drug Delivery

by Application - Respiratory Disorders, Neurological Disorders,

Pain Management and Other Applications Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2016 through

2019 and % CAGR



Table 57: Europe 11-Year Perspective for Intranasal Drug

Delivery by Application - Percentage Breakdown of Value Sales

for Respiratory Disorders, Neurological Disorders, Pain

Management and Other Applications for the Years 2016, 2021 &

2027



Table 58: Europe Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Geographic Region - France,

Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2020 through 2027 and % CAGR



Table 59: Europe Historic Review for Intranasal Drug Delivery

by Geographic Region - France, Germany, Italy, UK, Spain,

Russia and Rest of Europe Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2016 through 2019 and %

CAGR



Table 60: Europe 11-Year Perspective for Intranasal Drug

Delivery by Geographic Region - Percentage Breakdown of Value

Sales for France, Germany, Italy, UK, Spain, Russia and Rest of

Europe Markets for Years 2016, 2021 & 2027



FRANCE

Intranasal Drug Delivery Market Presence - Strong/Active/Niche/

Trivial - Key Competitors in France for 2022 (E)

Table 61: France Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Product Type - Liquid Delivery

Devices, Powder Delivery Devices, Pressurized Metered Dose

Inhalers and Other Product Types - Independent Analysis of

Annual Sales in US$ Million for the Years 2020 through 2027 and

% CAGR



Table 62: France Historic Review for Intranasal Drug Delivery

by Product Type - Liquid Delivery Devices, Powder Delivery

Devices, Pressurized Metered Dose Inhalers and Other Product

Types Markets - Independent Analysis of Annual Sales in US$

Million for Years 2016 through 2019 and % CAGR



Table 63: France 11-Year Perspective for Intranasal Drug

Delivery by Product Type - Percentage Breakdown of Value Sales

for Liquid Delivery Devices, Powder Delivery Devices,

Pressurized Metered Dose Inhalers and Other Product Types for

the Years 2016, 2021 & 2027



Table 64: France Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Application - Respiratory

Disorders, Neurological Disorders, Pain Management and Other

Applications - Independent Analysis of Annual Sales in US$

Million for the Years 2020 through 2027 and % CAGR



Table 65: France Historic Review for Intranasal Drug Delivery

by Application - Respiratory Disorders, Neurological Disorders,

Pain Management and Other Applications Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2016 through

2019 and % CAGR



Table 66: France 11-Year Perspective for Intranasal Drug

Delivery by Application - Percentage Breakdown of Value Sales

for Respiratory Disorders, Neurological Disorders, Pain

Management and Other Applications for the Years 2016, 2021 &

2027



GERMANY

Intranasal Drug Delivery Market Presence - Strong/Active/Niche/

Trivial - Key Competitors in Germany for 2022 (E)

Table 67: Germany Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Product Type - Liquid Delivery

Devices, Powder Delivery Devices, Pressurized Metered Dose

Inhalers and Other Product Types - Independent Analysis of

Annual Sales in US$ Million for the Years 2020 through 2027 and

% CAGR



Table 68: Germany Historic Review for Intranasal Drug Delivery

by Product Type - Liquid Delivery Devices, Powder Delivery

Devices, Pressurized Metered Dose Inhalers and Other Product

Types Markets - Independent Analysis of Annual Sales in US$

Million for Years 2016 through 2019 and % CAGR



Table 69: Germany 11-Year Perspective for Intranasal Drug

Delivery by Product Type - Percentage Breakdown of Value Sales

for Liquid Delivery Devices, Powder Delivery Devices,

Pressurized Metered Dose Inhalers and Other Product Types for

the Years 2016, 2021 & 2027



Table 70: Germany Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Application - Respiratory

Disorders, Neurological Disorders, Pain Management and Other

Applications - Independent Analysis of Annual Sales in US$

Million for the Years 2020 through 2027 and % CAGR



Table 71: Germany Historic Review for Intranasal Drug Delivery

by Application - Respiratory Disorders, Neurological Disorders,

Pain Management and Other Applications Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2016 through

2019 and % CAGR



Table 72: Germany 11-Year Perspective for Intranasal Drug

Delivery by Application - Percentage Breakdown of Value Sales

for Respiratory Disorders, Neurological Disorders, Pain

Management and Other Applications for the Years 2016, 2021 &

2027



ITALY

Table 73: Italy Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Product Type - Liquid Delivery

Devices, Powder Delivery Devices, Pressurized Metered Dose

Inhalers and Other Product Types - Independent Analysis of

Annual Sales in US$ Million for the Years 2020 through 2027 and

% CAGR



Table 74: Italy Historic Review for Intranasal Drug Delivery by

Product Type - Liquid Delivery Devices, Powder Delivery

Devices, Pressurized Metered Dose Inhalers and Other Product

Types Markets - Independent Analysis of Annual Sales in US$

Million for Years 2016 through 2019 and % CAGR



Table 75: Italy 11-Year Perspective for Intranasal Drug

Delivery by Product Type - Percentage Breakdown of Value Sales

for Liquid Delivery Devices, Powder Delivery Devices,

Pressurized Metered Dose Inhalers and Other Product Types for

the Years 2016, 2021 & 2027



Table 76: Italy Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Application - Respiratory

Disorders, Neurological Disorders, Pain Management and Other

Applications - Independent Analysis of Annual Sales in US$

Million for the Years 2020 through 2027 and % CAGR



Table 77: Italy Historic Review for Intranasal Drug Delivery by

Application - Respiratory Disorders, Neurological Disorders,

Pain Management and Other Applications Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2016 through

2019 and % CAGR



Table 78: Italy 11-Year Perspective for Intranasal Drug

Delivery by Application - Percentage Breakdown of Value Sales

for Respiratory Disorders, Neurological Disorders, Pain

Management and Other Applications for the Years 2016, 2021 &

2027



UNITED KINGDOM

Intranasal Drug Delivery Market Presence - Strong/Active/Niche/

Trivial - Key Competitors in the United Kingdom for 2022 (E)

Table 79: UK Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Product Type - Liquid Delivery

Devices, Powder Delivery Devices, Pressurized Metered Dose

Inhalers and Other Product Types - Independent Analysis of

Annual Sales in US$ Million for the Years 2020 through 2027 and

% CAGR



Table 80: UK Historic Review for Intranasal Drug Delivery by

Product Type - Liquid Delivery Devices, Powder Delivery

Devices, Pressurized Metered Dose Inhalers and Other Product

Types Markets - Independent Analysis of Annual Sales in US$

Million for Years 2016 through 2019 and % CAGR



Table 81: UK 11-Year Perspective for Intranasal Drug Delivery

by Product Type - Percentage Breakdown of Value Sales for

Liquid Delivery Devices, Powder Delivery Devices, Pressurized

Metered Dose Inhalers and Other Product Types for the Years

2016, 2021 & 2027



Table 82: UK Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Application - Respiratory

Disorders, Neurological Disorders, Pain Management and Other

Applications - Independent Analysis of Annual Sales in US$

Million for the Years 2020 through 2027 and % CAGR



Table 83: UK Historic Review for Intranasal Drug Delivery by

Application - Respiratory Disorders, Neurological Disorders,

Pain Management and Other Applications Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2016 through

2019 and % CAGR



Table 84: UK 11-Year Perspective for Intranasal Drug Delivery

by Application - Percentage Breakdown of Value Sales for

Respiratory Disorders, Neurological Disorders, Pain Management

and Other Applications for the Years 2016, 2021 & 2027



SPAIN

Table 85: Spain Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Product Type - Liquid Delivery

Devices, Powder Delivery Devices, Pressurized Metered Dose

Inhalers and Other Product Types - Independent Analysis of

Annual Sales in US$ Million for the Years 2020 through 2027 and

% CAGR



Table 86: Spain Historic Review for Intranasal Drug Delivery by

Product Type - Liquid Delivery Devices, Powder Delivery

Devices, Pressurized Metered Dose Inhalers and Other Product

Types Markets - Independent Analysis of Annual Sales in US$

Million for Years 2016 through 2019 and % CAGR



Table 87: Spain 11-Year Perspective for Intranasal Drug

Delivery by Product Type - Percentage Breakdown of Value Sales

for Liquid Delivery Devices, Powder Delivery Devices,

Pressurized Metered Dose Inhalers and Other Product Types for

the Years 2016, 2021 & 2027



Table 88: Spain Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Application - Respiratory

Disorders, Neurological Disorders, Pain Management and Other

Applications - Independent Analysis of Annual Sales in US$

Million for the Years 2020 through 2027 and % CAGR



Table 89: Spain Historic Review for Intranasal Drug Delivery by

Application - Respiratory Disorders, Neurological Disorders,

Pain Management and Other Applications Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2016 through

2019 and % CAGR



Table 90: Spain 11-Year Perspective for Intranasal Drug

Delivery by Application - Percentage Breakdown of Value Sales

for Respiratory Disorders, Neurological Disorders, Pain

Management and Other Applications for the Years 2016, 2021 &

2027



RUSSIA

Table 91: Russia Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Product Type - Liquid Delivery

Devices, Powder Delivery Devices, Pressurized Metered Dose

Inhalers and Other Product Types - Independent Analysis of

Annual Sales in US$ Million for the Years 2020 through 2027 and

% CAGR



Table 92: Russia Historic Review for Intranasal Drug Delivery

by Product Type - Liquid Delivery Devices, Powder Delivery

Devices, Pressurized Metered Dose Inhalers and Other Product

Types Markets - Independent Analysis of Annual Sales in US$

Million for Years 2016 through 2019 and % CAGR



Table 93: Russia 11-Year Perspective for Intranasal Drug

Delivery by Product Type - Percentage Breakdown of Value Sales

for Liquid Delivery Devices, Powder Delivery Devices,

Pressurized Metered Dose Inhalers and Other Product Types for

the Years 2016, 2021 & 2027



Table 94: Russia Recent Past, Current & Future Analysis for

Intranasal Drug Delivery by Application - Respiratory

Disorders, Neurological Disorders, Pain Management and Other

Applications - Independent Analysis of Annual Sales in US$



Please contact our Customer Support Center to get the complete Table of Contents

Read the full report: https://www.reportlinker.com/p05436898/?utm_source=GNW



About Reportlinker

ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.



__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001